跳至主要内容
临床试验/NCT07353996
NCT07353996招募中4 期

Determination of the Effective Dose of a Single Intravenous Dose of Tegileridine Fumarate for Postoperative Analgesia After Orthopedic Surgery: A Up-and-Down Sequential Allocation Study

Second Affiliated Hospital, School of Medicine, Zhejiang University0 个研究点目标入组 180 人开始时间: 2025年10月25日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
180

研究概览

简要总结

The goal of this clinical trial is to determine the 90% effective dose (ED90) of a single intravenous injection of tegileridine fumarate for postoperative analgesia in adult patients aged 18-75 years with American Society of Anesthesiologists (ASA) physical status I-III undergoing orthopedic surgery, including spinal fusion surgery, femoral fracture fixation, and total knee arthroplasty.

The main questions this study aims to answer are:

What is the ED90 of a single intravenous dose of tegileridine fumarate for achieving adequate postoperative analgesia, defined as a Numeric Rating Scale (NRS) pain score ≤ 3 within 30 minutes after awakening from anesthesia without the need for rescue analgesia?

Participants will:

Receive a single intravenous injection of tegileridine fumarate during skin closure at the end of surgery.

Start with an initial dose of 0.5 mg, with subsequent doses adjusted upward or downward in 0.1 mg increments for the next participant based on the analgesic response of the preceding participant, following a biased-coin up-and-down sequential dose allocation design.

Be closely monitored during the postoperative recovery period for pain intensity, vital signs (including heart rate, blood pressure, respiratory rate, and oxygen saturation), and adverse reactions such as nausea, vomiting, respiratory depression, agitation, and other opioid-related side effects.

This study aims to identify an optimal single-dose regimen of tegileridine fumarate that provides effective postoperative analgesia with an acceptable safety profile, thereby improving postoperative pain control and promoting enhanced recovery in patients undergoing orthopedic surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 to 75 years.
  • Scheduled for elective orthopedic surgery, including spinal fusion, femoral fracture fixation, or total knee arthroplasty.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Ability to understand the study procedures and provide written informed consent.

排除标准

  • Patients with moderate to severe obesity (BMI > 30 kg/m²).
  • Known hypersensitivity or allergy to tegileridine fumarate or other analgesics.
  • History of chronic pain or long-term use of opioids.
  • Severe hepatic or renal impairment.
  • Patients requiring postoperative ICU care.
  • Severe respiratory depression (e.g., oxygen saturation < 90%).
  • Known or suspected gastrointestinal obstruction, including paralytic ileus.

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

相似试验